Algo version: 0.98b
Evolus Inc is listed at the LSE Exchange
Evolus Inc [0K16.L]
LSE Sector: Healthcare Industry:Medical Pharmaceuticals

Is Evolus Inc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Evolus Inc pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Tuesday 15th of March 2022 were paid $0.285 per share. Over the last 1 times between 2022 and 2022, Evolus Inc has paid $0.285 with an average of $0.29 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Evolus Inc 10 years ago, but if you had invested on Wednesday 13th of January 2021 when the price was $5.88, you would have made a profit of $6.61 per share or 112.41%

No, the average daily trading liquidity for Evolus Inc is $1 394 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Evolus Inc has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Evolus Inc to be medium [0.7 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.